ESLAW Estrella Immunopharma, Inc.

Fundamentals / CIK 0001844417 / USD
Other share classes on CIK 0001844417: ESLA

Estrella Immunopharma, Inc. reported $1.67M in total assets and a net loss of $12.59M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ESLAW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$0$0$0-$12.21MFY 2021 Net Income: -$248K2021FY 2022 Net Income: -$996K2022FY 2023 Net Income: -$11.11M2023FY 2024 Net Income: -$7.31M2024FY 2025 Net Income: -$13.06M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Jun 30 Jun 30 Dec 31 Dec 31
Research & Development $10.25M $4.11M $10.45M -- --
Total Operating Expenses $13.06M $7.31M $11.11M -- --
Operating Income -$13.06M -$7.31M -$11.11M -$1.57M -$249K
Interest Income -- -- -- $654K $1.4K
Income Before Tax -$13.06M -$7.31M -$11.11M -$915K -$248K
Income Tax Expense $838 $1.6K -- $81K $0
Net Income -$13.06M -$7.31M -$11.11M -$996K -$248K
Basic EPS -$0.35 -$0.27 -$36.35 -- --
Diluted EPS -$0.35 -$0.27 -$36.35 -- --
Basic Shares Outstanding 36.8M 27.1M 305.7K -- 1.2M
Diluted Shares Outstanding 36.8M 27.1M 305.7K -- 1.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $6.90M $1.40M $1.40M $25K $4.15M $4.66M $1.41M $33K
Total Operating Expenses $7.50M $2.08M $2.29M $680K $4.73M $5.54M $2.10M $1.05M
Operating Income -$7.50M -$2.08M -$2.29M -$680K -$4.73M -$5.54M -$2.10M -$1.05M
Income Before Tax -$7.38M -$2.31M -$2.29M -$613K -$4.80M -$5.54M -$2.10M -$1.05M
Income Tax Expense -- -- -- -$25 $0 $850 $13 --
Net Income -$7.38M -$2.31M -$2.29M -$613K -$4.80M -$5.54M -$2.10M -$1.05M
Basic EPS -$0.17 -$0.05 -$0.05 -- -$0.13 -$0.15 -$0.06 --
Diluted EPS -$0.17 -$0.05 -$0.05 -- -$0.13 -$0.15 -$0.06 --
Basic Shares Outstanding 43.6M 43.0M 42.1M -- 37.1M 36.2M 36.2M --
Diluted Shares Outstanding 43.6M 43.0M 42.1M -- 37.1M 36.2M 36.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Jun 30 Jun 30 Dec 31 Dec 31
Cash & Cash Equivalents $1.38M $917K $4.17M $2.48M $41K $479K
Cash & Short-Term Investments $1.38M $917K $4.17M $2.48M $41K $479K
Accounts Receivable, Net -- -- -- $273K -- --
Total Current Assets $1.68M $1.64M $4.45M $2.75M $52K $616K
Total Non-Current Assets $1.50M $1.50M $0 $276K $9.67M $45.19M
Total Assets $3.18M $3.14M $4.45M $3.03M $9.72M $45.80M
Total Current Liabilities $13.54M $3.00M $181K $9.76M $1.07M $73K
Other Non-Current Liabilities -- -- -- $13K -- --
Total Non-Current Liabilities $0 $0 $0 $13K $1.58M $1.55M
Total Liabilities $13.54M $3.00M $181K $9.77M $2.65M $1.62M
Common Stock $3.8K $3.7K $3.7K $98 $142 $142
Retained Earnings -$36.99M -$23.93M -$19.50M -$12.19M -$2.26M -$1.01M
Total Stockholders' Equity -$10.37M $144K $4.27M -$11.74M -$6.48M -$1.01M
Total Equity -$10.37M $144K $4.27M -$11.74M -$6.48M -$1.01M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $100K $100K -- $1.38M $1.63M $1.32M $421K $917K
Cash & Short-Term Investments $100K $100K -- $1.38M $1.63M $1.32M $421K $917K
Total Current Assets $1.67M $1.82M $2.16M $1.68M $2.02M $1.48M $944K $1.64M
Total Non-Current Assets $0 $0 $1.50M $1.50M $1.50M $1.50M $1.50M $1.50M
Total Assets $1.67M $1.82M $3.66M $3.18M $3.52M $2.98M $2.44M $3.14M
Total Current Liabilities $15.64M $9.26M $8.93M $13.54M $13.36M $9.08M $4.28M $3.00M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $15.64M $9.26M $8.93M $13.54M $13.36M $9.08M $4.28M $3.00M
Common Stock $4.4K $4.4K $4.3K $3.8K $3.8K $3.8K $3.7K $3.7K
Retained Earnings -$48.97M -$41.59M -$39.28M -$36.99M -$36.38M -$31.58M -$26.03M -$23.93M
Total Stockholders' Equity -$13.97M -$7.43M -$5.27M -$10.37M -$9.84M -$6.09M -$1.83M $144K
Total Equity -$13.97M -$7.43M -$5.27M -$10.37M -$9.84M -$6.09M -$1.83M $144K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Jun 30 Jun 30 Dec 31 Dec 31
Net Income -$13.06M -$7.31M -$11.11M -$996K -$248K
Stock-Based Compensation $619K $1.19M $410K -- --
Operating Cash Flow -$1.79M -$16.07M -$1.34M -$1.04M -$316K
Investing Cash Flow -- $4.96M -$273K $36.17M -$45.19M
Common Stock Issued $2.40M -- -- -- $25K
Share Repurchases -$29K -- -- -- --
Financing Cash Flow $2.25M $12.79M -- -$35.56M $45.98M
Net Change in Cash $467K $1.69M -$1.61M -$438K $479K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$7.38M -$2.31M -$2.29M -$613K -$4.80M -$5.54M -$2.10M -$1.05M
Stock-Based Compensation $106K $145K $147K $148K $152K $159K $159K $432K
Operating Cash Flow -$217K -$1.78M -$6.70M -$177K -$727K -$415K -$466K -$896K
Common Stock Issued $0 $0 $8.00M -- -- -- -- --
Share Repurchases -- -- -- $0 $0 $0 -$29K --
Financing Cash Flow $163K $4 $7.24M -$65K $1.04M $1.31M -$29K $15K
Net Change in Cash -$54K -$1.78M $543K -$242K $310K $895K -$495K -$881K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Jun 30 Jun 30 Dec 31 Dec 31
Return on Equity (ROE) -- -171.1% -- -- --
Return on Assets (ROA) -411.2% -164.2% -367.0% -10.2% -0.5%
Current Ratio 0.12x 24.65x 0.28x 0.05x 8.42x
Quick Ratio 0.10x 23.05x 0.28x 0.04x 6.55x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -- -- -- -- -- -- -6155.7%
Return on Assets (ROA) -753.6% -548.7% -362.3% -411.2% -383.2% -405.2% -428.9% -281.7%
Current Ratio 0.11x 0.20x 0.24x 0.12x 0.15x 0.16x 0.22x 0.55x
Quick Ratio 0.01x 0.01x -- 0.10x 0.12x 0.15x 0.10x 0.31x
Source: SEC EDGAR CompanyFacts (CIK 0001844417) · from March 31, 2021 Data through September 30, 2026 · synced Nov 21, 2026, 05:01 UTC · Open in terminal